We are dedicated to a transformation in cancer care driven by the belief that the more we know about cancer’s molecular underpinnings, the better we can help physicians make the best treatment decisions for their patients. Through richer science, deeper insights, and stronger partnerships—we’re redefining the way cancer is treated.
Discover the only FDA-approved portfolio of comprehensive genomic profiling tests for all solid tumors. With FDA approvals for tissue- and blood-based tests, our portfolio can help guide treatment strategies for advanced cancer patients.
Contact:
Brittany Lorber
760.685.0048
E-mail - blorber@foundationmedicine.com
Featured Content
